The purpose of this systematic review and meta-analysis is to define the current knowledge on maternal circulating leptin levels during pregnancy in GDM, as a biochemical mediator associated with its pathophysiology and their potential use as risk markers for GDM development, and to identify important evidence gaps. The gene discussed is LEP; the disease is gestational diabetes.